Rohto has picked up a 13 per cent stake in the step-down subsidiary, Sastasundar Healthbuddy, through its $5-million investment.
Rohto Pharmaceutical Co., Ltd. (“Rohto”) Japan, on Thursday, announced a Capital and Business Alliance with Kolkata based SastaSundar Healthbuddy Limited, a wholly owned subsidiary of SastaSundar Ventures Limited, an NSE and BSE listed company, owning and operating SastaSundar.com, a leading digital network of healthcare in India. Rohto has invested $5 million (Rs 32.2 crores) in SastaSundar Healthbuddy Limited for 24,35,583 shares and is likely to make further investments as the business progresses. This investment was done @ Rs 132 per share & considering Mcap of 247 to this company.
Established in 1899, Rohto initially played a role in every customer’s welfare with its drugs including unique eye drops and gastrointestinal medicines. Later, the company successfully ventured into dermal medicines, skin care, and functional foods.
SastaSundar.com is building India’s leading digital network of healthcare, managing efficient pharma & wellness products’ supply chain & connecting doctors, diagnostic services, healthcare clinics and health information services. Currently, SastaSundar.com is operating in West Bengal only and will expand to pan India. The digital network of SastaSundar.com is being built upon the online to offline model of healthcare delivery leveraging technology and inventory less service centre of the franchise called Healthbuddy.